The oligonucleotide ligation assay (OLA) 
INTRODUCTION
Arylamines have been implicated in the pathogenesis of certain types of cancer such as that of the bladder and colon. Acetylation is an important step in the metabolic activation and deactivation of arylamines. The human capacity to acetylate arylamines is subject to a genetic polymorphism. Individuals segregate into rapid or slow acetylator phenotypes regulated by a single gene coding for a polymorphic acetyltransferase isozyme (NAT2; References 3,9 and 15). Nine different point mutations have been found in the NAT2gene (1, 3, 5, 12, 19) , seven of which lead to amino acid changes: G to A at nucleotide (nt) position 191 (Arg to Glu), T to C at nt position 341 (Ile to Thr), A to C at nt position 434 (Gln to Pro), G to A at nt position 590 (Arg to Gln), A to G at nt position 803 (Lys to Arg), A to C at nt position 845 (Lys to Thr) and G to A at nt position 857 (Gly to Glu). The remaining two C to T point mutations at nt positions 282 and 481 cause no amino acid changes. Alleles containing any of the missense mutations at nt positions 191, 341, 590 and 857 produce an enzyme that metabolizes its substrates more slowly, and individuals with two mutated NAT2alleles are slow acetylators (4, 5, 17) . The prevalence of slow acetylator alleles and phenotypes is high but varies considerably among different ethnic groups (1, 4, 11, 12) . Slow and rapid acetylator phenotypes differ in occurrence and susceptibility to certain types of cancer. The NAT2 slow acetylator phenotype is a significant risk factor for the occurrence of bladder cancer, while rapid acetylators may be at higher risk of developing cancer of the colon (8, 16) .
With the increased interest in genetic predisposition to environmentally influenced cancers, such as bladder and colon cancer, the number and size of epidemiological studies is increasing. To date, restriction fragment length polymorphism (RFLP; References 1,10 and 18), allele-specific polymerase chain reaction (PCR; References 2,11 and 17) or a combination of both methods (4,7) has been used to determine NAT2 genotypes in epidemiological studies. However, due to the limited possibilities for automation, PCR/ RFLP and allele-specific amplification are not particularly well-suited to the processing of large numbers of samples. Since our study requires the genotyping of several thousand DNA samples, we were looking for a method that allows more efficient processing of such a large number. We therefore adapted the enzyme-linked immunosorbent assay (ELISA)-based oligonucleotide ligation assay (OLA; Reference 14), first developed for the diagnosis of genetic diseases such as sickle cell anemia and cystic fibrosis, to the genotyping of the NAT2gene. This method has not previously been described for NAT2genotyping. The advantage of this assay is that it can be automated by using robotic workstations for pipetting and a plate reader to record the results. The use of automated equipment reduces the error rate and allows faster and more efficient processing of samples. In our experience, OLA has yielded more consistent results than allele-specific amplification. It is also more cost-effective than RFLP or allele-specific amplification, especially for larger studies.
We limited our analysis to the NAT2 missense mutations G191A, T341C, G590A, A803G and G857A. Although two additional missense mutations, A434C and A845C, were described (12), they were found respectively in only one individual out of 803 tested (12) , and they were not found in a different study testing 844 individuals (4) . Because of their low frequency of occurrence, these two missense mutations are not included in our study. The two silent mutations at nt positions 282 and 481 do not appear to influence enzyme activity (2, 4) .
MATERIALS AND METHODS

DNA Extraction
Genomic DNA was extracted from the peripheral white blood cells of 90 specimens from the Genetic Epidemiologic Studies of Colon Polyps and Cancer project, a collaboration among the Fred Hutchinson Cancer Research Center, the University of Minnesota, the University of Utah and the Kaiser Permanente of California. Established procedures using a sodium dodecyl sulfate-proteinase K digestion and sodium chloride extraction were followed (13) .
PCR Amplification
Primers 5 ′ GGAACAAATTGGATT -GG3 ′ and 5 ′ TCTAGCATGAATCACT -CTGC3 ′ (1) were used to amplify the NAT2coding region from 100 ng genomic DNA in 50-µ L reactions containing 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.001% gelatin (Perkin-Elmer, Norwalk, CT, USA), 50 µ g/mL bovine serum albumin (BSA), 0.2 µ M primers, 0.2 mM dNTPs and 1 U AmpliTaq ® DNA Polymerase (Perkin-Elmer). The cycling conditions on a PTC-100 ™ Thermal Cycler (MJ Research, Watertown, MA, USA) or DeltaCycler II ™Thermal Cycler (Ericomp, San Diego, CA, USA) were: 4 min at 94°C, followed by 40 cycles at 94°C for 30 s, 57°C for 45 s, 72°C for 90 s and a final extension at 72°C for 5 min (1).
Ligation/ELISA Assay
The PCR was diluted with 80 µ L 0.1% Triton ® X-100. A Biomek ® 2000 Robotic Workstation (Beckman Instruments, Fullerton, CA, USA) was used to set up the ligation reactions. For each mutation, two ligation reactions were set up containing either wild-type or mutant primer (6) 
RESULTS AND DISCUSSION
The NAT2genotype for 90 individuals was determined by the OLA. Figure  1 shows representative genotyping results for three samples. Figure 1A depicts the results for a homozygous wild-type individual, or fast acetylator; Figure 1 , B and C, shows slow acetylators. The individual in Figure 1B carries the missense mutation at nt positions 590 and 857 and is therefore a slow acetylator (4, 17) . The individual depicted in Figure 1C is homozygous for the missense mutations at nt positions 341 and 803 and therefore is also a slow acetylator phenotype. Table 2 shows a summary of the optical density (OD) 495 
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mentary to the wild-type or mutant ligation primers, whereas all the fragments can serve as templates for either the wild-type or the mutant primers in homozygous samples. Since the OD 495 is proportional to the amount of PCR template, the data are presented separately for homozygous and heterozygous individuals. As shown in Table 2 , the OD 495 obtained from heterozygous samples tends to be lower than from homozygous samples for the same mutation. As Figure 1 and Table 2 show, the absolute OD 495 readings can vary between the samples and the mutations. The variables most likely to influence the OD 495 are: (i) the amount of PCR fragment obtained in the initial amplification, (ii) the efficiency of the digoxigenin-tailing and (iii) the efficiency of the biotinylation. However, these differences do not usually cause problems with the determination of the genotypes; as the results presented in Table  2 show, the mismatched primer in the ligation reaction results in an OD 495 of 5% or less of the value obtained for the matched primer of a particular polymorphism.
To determine the accuracy of the OLA, we compared the genotyping results with those obtained by RFLP for the two most frequently occurring mutations, T341C and G590A. The restriction enzymes used were Kpn I for the T341C mutation and Taq I for the G590A mutation. For the G590A mutation, we did not observe any genotyping discrepancies between the two assays in the 90 samples tested. The mutation frequencies are shown in Tables 2 and 3. Thus, the OLA is as accurate as RFLP for genotyping.
The OLA showed advantages over RFLP for genotyping for the nt T341C. This mutation is not part of a restriction site but was reported to be linked to the mutation at nt position 481, which inactivates a Kpn I restriction site (2). Therefore, when genotyping NAT2by RFLP, digestion with Kpn I has been used as an indirect diagnostic tool for the mutation at nt position 341 (1,12,18,19 ). An alternative RFLP method by which the polymorphism at nt position 341 can be assessed directly using the restriction endonuclease Aci I has been described only recently (7). Our analysis revealed discrepancies between the direct OLA method and the identification of an RFLP with Kpn I for four samples. All four samples contained no mutation at nt position 481 ( Kpn I site) but carried the nt 341 missense mutation. As our data presented in Table 3 show, 5% (4/71) of the alleles carrying the nt 341 mutations are misidentified as wildtype if genotyped by RFLP using Kpn I. All four alleles that contained the wildtype Kpn I site, but were mutated at nt position 341, also carried a mutation at nt position 803 and thus are identical to the recently identified NAT2 *5C allele (Reference 4; for NAT2allele nomenclature see Reference 20) . The NAT2 genotype frequencies observed for the 90 individuals analyzed (Table 3) are similar to findings reported in other studies (1, 4, 11) . In addition to the OLA and RFLP using Aci I, allele-specific PCR is a method by which the genotype at nt position 341 can be determined directly (2). However, in our experience, results obtained with the OLA are more consistent than those obtained with allele-specific amplification (data not shown). It appears that the thermostable ligase used to ligate biotinylated wild-type or mutant primers with the digoxigenin-tailed common primer is highly sensitive to mismatched base pairs, whereas PCR amplification using a mismatched primer can still occur, but at a lower efficiency compared to the matched primer.
The use of robotic workstations for the assembly of the ligation reactions and the transfer of the ligation samples to the ELISA plates greatly facilitate sample handling. Furthermore, these workstations reduce or eliminate pipetting errors and improve the efficiency and accuracy of the reactions. The OD 495 results are read by a plate reader and can be exported directly to a spreadsheet program, thereby facilitating data management and eliminating data entry errors-a crucial issue in large-scale epidemiological studies. 
An added advantage of the OLA is the fact that a single 50-µ L PCR containing 100 ng genomic DNA yields sufficient amounts of amplified NAT2 fragment to test all five missense mutations, thereby reducing the amount of genomic DNA required for the analysis. This too is an important consideration for epidemiological studies where the DNA supply may be limited. PCR/RFLP of the five missense mutations requires at least two PCRs (4). One initial PCR amplifies the entire coding region, and a subsequent PCR with nested primers is used to amplify a smaller fragment encompassing the mutation at nt position 803 to obtain a simpler restriction fragment pattern. Another PCR is necessary to genotype the nt 341 polymorphism by RFLP by Aci I. Allele-specific amplification can require up to 10 PCRs needing genomic DNA if the allele-specific primers are used directly (2) . We found the OLA to be an accurate and efficient method for NAT2genotyping and suitable for the processing of large numbers of samples. 
INTRODUCTION
Detection of sequence differences in DNA samples is useful for many applications including positional cloning, the generation of high-resolution genetic maps and inheritance analysis. Random amplified polymorphic DNA (RAPD) allows the generation of many potentially polymorphic fragments from a single short primer (usually a decamer) of arbitrary sequence in a polymerase chain reaction (PCR). These fragments are usually detected using agarose gel electrophoresis and ethidium bromide (EtdBr) staining (7, 10) . We present a technique using polyacrylamide gel electrophoresis (PAGE), fluorescence detection and inlane size markers that increases the sensitivity and reliability of identification of RAPD products.
The Model 373A DNA Sequencer and GENESCAN™672 collection and analysis programs (both from PE
